Loading...
Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
BACKGROUND: For Canadian men, prostate cancer (PCa) is the most common cancer and the 3rd leading cause of cancer mortality. Men dying of PCa do so after failing castration. The management of metastatic castration-resistant prostate cancer (mCRPC) is complex and the associated drug treatments are in...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4099156/ https://ncbi.nlm.nih.gov/pubmed/24927758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-14-252 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|